Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein InvasionMinke He, Ming Shi, Yuan-Min Zhou et al.|JAMA Oncology|2019Cited by 559
MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinomaHanyue Ouyang, Ming Shi, Jing Xu et al.|Hepatology|2015Cited by 49
Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolizationYong‐Fa Zhang, Ming Shi, Wei Wei et al.|Liver International|2016Cited by 1